Cargando...
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues upon dose escalation, ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumour-associated target antigens and...
Guardado en:
| Publicado en: | Biosci Rep |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Portland Press Ltd.
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613712/ https://ncbi.nlm.nih.gov/pubmed/26182432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20150089 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|